Close monitoring by a multidisciplinary teamincluding bariatric surgeons, endocrinologists, dietitians, and GPsis essential to ensure safe and effective use
all subjects who were randomised and exposed to at least one dose of trial product), while safety analyses were conducted in the safety analysis set (SAS
HPLC can show the relative size of detected chromatographic peaks, but HPLC area percentage alone does not confirm the chemical identity or account for every possible impurity
24 Further, there are certain disadvantages to consider with some of the options, such as weight gain and/or hypoglycemia associated with the use of TZDs, SUs, and insulin
Understanding the process ensures a smooth transition and helps you maintain the glycaemic control achieved during treatment
doi:10.1089/thy.1996.6.305